1 completed, 1 unknown. 2 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 2 | Completed 1, Unknown 1 |
| Phase 2 | 1 | Unknown 1 |
Follow Lymphomatoid Granulomatosis: new trials by email Literature Review of Lymphomatoid Granulomatosis trials Research Report on Lymphomatoid Granulomatosis
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Study to Evaluate Safety and Tolerability of XmAb13676 (Plamotamab) in Patients With CD20-expressing Hematologic Malignancies XmAb13676 - B-cell Non-Hodgkins Lymphoma, Chronic Lymphocytic Leukemia | Phase 1 | Completed | Xencor, Inc. | 154 | 2016-10-01 | 2024-11-13 |
| Gene Therapy for B-Cell Non-Hodgkin Lymphoma Using CD19 CAR Gene Transduced T Lymphocytes Cyclophosphamide or Bendamustine, Dose Level -1, Dose Level 1 - Relapsed or Refractory B-Cell Non-Hodgkin Lymphoma | Phase 1 / Phase 2 | Unknown | Jichi Medical University | 18 | 2014-05-01 | 2014-11-06 |
Burkitt Lymphoma (2) · Lymphoma, B-Cell (2) · Lymphoma, B-Cell, Marginal Zone (2) · Lymphoma, Follicular (2) · Lymphoma, Large B-Cell, Diffuse (2) · Lymphoma, Mantle-Cell (2) · Lymphoma, Non-Hodgkin (2) · Immune System Diseases (1) · Leukemia (1) · Leukemia, Hairy Cell (1) · Leukemia, Lymphocytic, Chronic, B-Cell (1) · Leukemia, Prolymphocytic, B-Cell (1) · Lymphoma (1) · Lymphoma, Extranodal NK-T-Cell (1)
DNA Virus Infections (2) · Disease Attributes (2) · Epstein-Barr Virus Infections (2) · Hemic and Lymphatic Diseases (2) · Herpesviridae Infections (2) · Immunoproliferative Disorders (2) · Infections (2) · Lymphatic Diseases (2) · Lymphoproliferative Disorders (2) · Pathologic Processes (2) · Pathological Conditions, Signs and Symptoms (2) · Precancerous Conditions (2) · Tumor Virus Infections (2) · Virus Diseases (2) · Blood Protein Disorders (1)
Bendamustine Hydrochloride (1) · Cyclophosphamide (1)
Jichi Medical University (1) · Xencor, Inc. (1)
France (1) · Japan (1) · South Korea (1) · United Kingdom (1) · United States (1)